VERU INC. Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share
VERU INC. (VERU) reported Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share of $0.00 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare · last filed 2026-08-10
- VERU INC. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for the quarter ending 2026-06-30 was $0.00.
- VERU INC. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for the quarter ending 2026-03-31 was $0.02.
- VERU INC. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for the quarter ending 2025-12-31 was $0.00.
- VERU INC. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for the quarter ending 2025-06-30 was $0.00.
- VERU INC. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for fiscal 2025 was -$0.48.
- VERU INC. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for fiscal 2024 was -$0.19.
| Period end | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 3 month | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 3 month as first filed | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 6 month | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 6 month as first filed | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 9 month | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-10 | $0.02 10-Q · filed 2026-08-10 | ||||
| 2026-03-31 | $0.02 10-Q · filed 2026-05-13 | $0.02 10-Q · filed 2026-05-13 | ||||
| 2025-12-31 | $0.00 10-Q · filed 2026-02-11 | |||||
| 2025-09-30 | -$0.48 10-K · filed 2025-12-17 | |||||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-10 | -$0.49 10-Q · filed 2026-08-10 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-13 | -$0.49 10-Q · filed 2026-05-13 | -$0.05 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | -$0.49 10-Q · filed 2026-02-11 | -$0.05 10-Q · filed 2025-02-13 | ||||
| 2024-09-30 | -$0.19 10-K · filed 2025-12-17 | |||||
| 2024-06-30 | -$0.04 10-Q · filed 2025-08-12 | -$0.20 10-Q · filed 2025-08-12 | ||||
| 2024-03-31 | -$0.01 10-Q · filed 2025-05-08 | -$0.02 10-Q · filed 2025-05-08 | ||||
| 2023-12-31 | -$0.01 10-Q · filed 2025-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |